Quarterly report pursuant to Section 13 or 15(d)

3. Summary of Significant Accounting Policies (Tables)

v2.4.0.6
3. Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2013
Notes to Financial Statements  
Inventories Table

The composition of inventory as of March 31, 2013 and December 31, 2012 is as follows: 

 

    March 31,     December 31,  
    2013     2012  
Raw materials   $ 180,408     $ 183,655  
Finished goods     760,445       789,707  
Inventory reserve     (50,000)     (50,000)
Total   $ 890,853     $ 923,362  

 

Customer Concentration

The following table illustrates the level of concentration as a percentage of total revenues during the three months ended March 31, 2013 and 2012:

 

    For the Three Months Ended  
    March 31,  
    2013     2012  
Top Five Customers     74 %     81 %
Federal Agencies     56 %     48 %

 

The following table illustrates the level of concentration as a percentage of net accounts receivable balance as of March 31, 2013 and December 31, 2012:

 

    March 31,     December 31,  
    2013     2012  
Top Five Customers     80 %     34 %
Federal Agencies     29 %     32 %

 

 

Computation of Loss per Share

The following table illustrates our computation of loss per share for the three months ended March 31, 2013 and 2012:

 

    For the Three Months Ended  
    March 31,  
    2013     2012  
Numerator:            
Net loss   $ (779,369)   $ (1,062,907)
Accrued dividend for Preferred Stock     (32,173)     (24,414)
Deemed dividend on Series J Convertible Preferred Stock     (582,548)     -  
Net loss applicable to common shareholders   $ (1,394,090)   $ (1,087,321)
                 
Denominator for basic and diluted loss per share:                
Weighted average common stock shares outstanding     12,149,267       7,712,359  
                 
Loss per common share - basic and diluted   $ (0.11)   $ (0.14)

 

Stockholders' Equity Activity Series C Preferred Convertible Securities Exchange

The Series C Convertible Preferred Stock, Series D Convertible Preferred Stock, Series G Convertible Preferred Stock and Series J Convertible Preferred Stock are presented below as if they were converted into common shares according to the conversion terms in Note 5.

 

    March 31,  
    2013     2012  
Stock options     1,605,750       1,555,500  
Convertible debt     -       50,000  
Common stock warrants     11,337,099       5,310,388  
Preferred stock warrants     -       -  
Convertible preferred stock:                
Series C Convertible Preferred     -       880,980  
Series D Convertible Preferred     750,000       461,539  
Series G Convertible Preferred     1,453,200       -  
Series J Convertible Preferred     4,650,000       -  
      19,796,049       8,258,407  

 

Stock based compensation expense

The following table summarizes the effect of this stock-based compensation expense within each of the line items of our costs and expenses within our Consolidated Statements of Operations:

 

    For the Three Months Ended March 31,  
    2013     2012  
Research and development   $ 4,836     $ 2,618  
Selling and marketing     3,668       3,113  
General and administrative     10,536       3,137  
Total stock-based compensation expense   $ 19,040     $ 8,868  

 

Liabilities measured at fair value on recurring basis

The following tables set forth the Company’s financial liabilities that were accounted for at fair value on a recurring basis as of March 31, 2013.

 

          Fair value measurements at March 31, 2013 using:  
    March 31, 2013    

Quoted prices in

active markets 

(Level 1)

   

Significant other observable inputs

(Level 2)

   

Significant

unobservable inputs 

(Level 3)

 
Series D Preferred Stock Purchase Warrants   $ 206,257       -       -     $ 206,257  
                                 

 

    January 1, 2013     Change in Fair Value     March 31, 2013  
Series D Preferred Stock Purchase Warrants   $ 160,812     $ 45,445     $ 206,257  
                         

Fair value assumptions

The assumptions for the binomial pricing model are represented in the table below for the warrants issued in the Series D private placement reflected on a per share Common Stock equivalent basis.

 

Assumptions   November 10, 2011  

Warrants revalued at

December 31, 2012

 

Warrants revalued at

March 31, 2013

Expected life (in months)   60.0   46.0   43.0
Expected volatility   104.5%   146.4%   133.7%
Risk-free interest rate   0.875%   0.44%   0.36%
Exercise price   $0.81   $0.40   $0.40
Fair value per warrant   $0.54   $0.15   $0.20